Our Commitment to Diversity, Equity, and Inclusion
In her latest Leadership Perspective, Executive Director Nakela L. Cook, MD, MPH, discusses her commitment to enhancing our work against racism, bias, and discrimination and promoting diversity, equity, and inclusion in all that we do. Read more
Results of ADAPTABLE Study on Aspirin Dosing Presented at ACC.21, Published in NEJM
In the largest aspirin dosing trial conducted in routine care and clinical settings, people with heart disease who took aspirin to lower their risk of a heart attack or stroke experienced similar benefits, whether they took high- or low-dose aspirin. Learn more
Biweekly COVID-19 Scan (May 13-26, 2021)
Our latest brief — in a series on the evolving landscape of potentially impactful applications for COVID-19 — covers cognitive rehabilitation therapy and tele-rehabilitation programs to treat post-COVID cognitive and pulmonary symptoms, respectively. Read more
PCORI, Korn Ferry Launch National Search for New Executive Team Role
Among the responsibilities of the new Deputy Executive Director for Patient-Centered Research Programs — who will report to PCORI's Executive Director — will be to provide strategic leadership and management oversight of activities related to funding of programs and projects. Learn more
Outcomes of Patients with Multiple Sclerosis Taking Certain Drugs
Findings published in the Annals of Clinical and Translational Neurology from the PCORI-funded COMBAT-MS Study's COVID-19 research enhancement show that patients taking the drug rituximab were at increased risk of hospitalization but not ventilatory support or death from COVID‐19, compared to the general population. Learn more
Learn About PCORI Funding Opportunities, Ways to Get Involved
During a recent webinar, PCORI leaders discussed way to get involved in patient-centered comparative clinical effectiveness research, improvements to our funding opportunities, and our three-year funding commitment plan. Watch
NIH-funded Study of Repurposed Drugs for COVID-19 Taps PCORnet
The NIH's ACTIV-6 clinical trial platform will use PCORnet®, the National Patient-Centered Clinical Research Network, to help accelerate the study of some prescription and over-the-counter medications as treatments for COVID-19 in non-hospitalized patients. Read more
Research Fundamentals
To help patients, caregivers and other interested stakeholders participate more fully in research, PCORI has launched this free, online training to gain a better understanding of the research process and patient-centered research. Find out more